HIGH VALLEYFIELD PHARMACY LIMITEDActive

Company number SC237258Private limited companyIncorporated 2002
⚠ Confirmation statement overdue. It was due on 8 Oct 2026.

Key figures

£544,064+27.9%
Net assets 2025
+16.6%
Average annual growth 2019/20–2025
0200 k400 k600 k2019/202020/212021/22202320242025

Like most small UK companies, HIGH VALLEYFIELD PHARMACY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2019/202020/212021/22202320242025
Filed accounts2019/20–2025
2020/212021/22202320242025
Cash at bank and in hand394,25980,485195,393236,831119,121
Total assets533,286676,383524,054650,764741,468
Total liabilities—————
Net assets / total equity364,239525,849349,730425,514544,064
Average number of employees97779

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HIGH VALLEYFIELD PHARMACY LIMITED

Company

HIGH VALLEYFIELD PHARMACY LIMITED is a private limited company registered with Companies House under company number SC237258. It was incorporated on 24 Sep 2002. Its status is active. The registered office is in Dunfermline (KY12). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £544,064, up 27.9% on the previous year. Cash at bank and in hand was £119,121. The company had an average of 9 employees. Figures are available for 6 financial years (2019/20–2025).

Control and charges

One person with significant control is registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 8 Oct 2026.